Cannon Advisors
RMD icon

Cannon Advisors’s ResMed RMD Stock Holding History

Cannon Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,442
Closed -$857K – 120
2026
Q2 		$857K Buy
+4,442
New +$921K 0.52% 46

Other funds holding RMD

Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
UniSuper Management
UniSuper Management Melbourne, Victoria, Australia $20.4B AUM 33.79% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Cannon Advisors's RMD Position: Q3 2026 in Review

Cannon Advisors sold out of ResMed (RMD) in Q3 2026, closing a stake of 4,442 shares — an estimated $857K sold.

Cannon Advisors first reported a position in RMD in Q2 2026 and held it in 1 quarter. The position peaked at $857K in Q2 2026. 204 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Cannon Advisors reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • Cannon Advisors sold 4,442 ResMed shares in Q3 2026, an estimated $857K.
  • Cannon Advisors first reported a position in ResMed in Q2 2026 and held it in 1 quarter.
  • Cannon Advisors's ResMed position peaked at $857K in Q2 2026.
  • 204 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Cannon Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.